Skip to main content
Top
Published in: BMC Pediatrics 1/2020

Open Access 01-12-2020 | Leukemia | Research article

Leukemia mortality in children from Latin America: trends and predictions to 2030

Authors: J. Smith Torres-Roman, Bryan Valcarcel, Pedro Guerra-Canchari, Camila Alves Dos Santos, Isabelle Ribeiro Barbosa, Carlo La Vecchia, Katherine A. McGlynn, Dyego Leandro Bezerra de Souza

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Reports suggest that Latin American and Caribbean (LAC) countries have not reduced leukemia mortality compared to high-income countries. However, updated trends remain largely unknown in the region. Given that leukemia is the leading cause of cancer-related death in LAC children, we evaluated mortality trends in children (0-14y) from 15 LAC countries for the period 2000–2017 and predicted mortality to 2030.

Methods

We retrieved cancer mortality data using the World Health Organization Mortality Database. Mortality rates (standardized to the world standard SEGI population) were analyzed for 15 LAC countries. We evaluated the average mortality rates for the last 5 years (2013–2017). Joinpoint regression analysis was used to evaluate leukemia mortality trends and provide an estimated annual percent change (EAPC). Nordpred was utilized for the calculation of predictions until 2030.

Results

Between 2013 and 2017, the highest mortality rates were reported in Venezuela, Ecuador, Nicaragua, Mexico, and Peru. Upward mortality trends were reported in Nicaragua (EAPC by 2.9% in boys, and EAPC by 2.0% in girls), and Peru (EAPC by 1.4% in both sexes). Puerto Rico experienced large declines in mortality among both boys (EAPC by − 9.7%), and girls (EAPC by − 6.0%). Leukemia mortality will increase in Argentina, Ecuador, Guatemala, Panama, Peru, and Uruguay by 2030.

Conclusion

Leukemia mortality is predicted to increase in some LAC countries by 2030. Interventions to prevent this outcome should be tailor to reduce the socioeconomic inequalities and ensure universal healthcare coverage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14–24.CrossRefPubMed Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14–24.CrossRefPubMed
2.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.PubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.PubMed
4.
go back to reference Bhatnagar N, Qureshi A, Hall G. Leukaemias: a review. Paediatr Child Health. 2017;27(11):489–94.CrossRef Bhatnagar N, Qureshi A, Hall G. Leukaemias: a review. Paediatr Child Health. 2017;27(11):489–94.CrossRef
5.
go back to reference Bertuccio P, Bosetti C, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. Int J Cancer. 2013;132(2):427–36.CrossRefPubMed Bertuccio P, Bosetti C, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. Int J Cancer. 2013;132(2):427–36.CrossRefPubMed
6.
go back to reference Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality. Cancer. 2014;120(16):2497–506.CrossRefPubMed Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality. Cancer. 2014;120(16):2497–506.CrossRefPubMed
7.
go back to reference Petridou ET, Dimitrova N, Eser S, Kachanov D, Karakilinc H, Varfolomeeva S, et al. Childhood leukemia and lymphoma: time trends and factors affecting survival in five southern and eastern European Cancer registries. Cancer Causes Control. 2013;24(6):1111–8.CrossRefPubMed Petridou ET, Dimitrova N, Eser S, Kachanov D, Karakilinc H, Varfolomeeva S, et al. Childhood leukemia and lymphoma: time trends and factors affecting survival in five southern and eastern European Cancer registries. Cancer Causes Control. 2013;24(6):1111–8.CrossRefPubMed
8.
go back to reference Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016;27(4):725–31.CrossRefPubMed Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016;27(4):725–31.CrossRefPubMed
9.
go back to reference Chatenoud L, Bertuccio P, Bosetti C, Levi F, Negri E, La Vecchia C. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer. 2010;116(21):5063–74.CrossRefPubMed Chatenoud L, Bertuccio P, Bosetti C, Levi F, Negri E, La Vecchia C. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer. 2010;116(21):5063–74.CrossRefPubMed
10.
go back to reference Curado MP, Pontes T, Guerra-Yi ME, Cancela MC. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Rev Panam Salud Publica. 2011;29:96–102.CrossRefPubMed Curado MP, Pontes T, Guerra-Yi ME, Cancela MC. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Rev Panam Salud Publica. 2011;29:96–102.CrossRefPubMed
11.
go back to reference Kehm RD, Spector LG, Poynter JN, Vock DM, Altekruse SF, Osypuk TL. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival? Cancer. 2018;124(20):4090–7.CrossRefPubMed Kehm RD, Spector LG, Poynter JN, Vock DM, Altekruse SF, Osypuk TL. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival? Cancer. 2018;124(20):4090–7.CrossRefPubMed
12.
go back to reference Silva-Junior AL, Alves FS, Kerr MWA, Xabregas LA, Gama FM, Rodrigues MGA, et al. Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: epidemiology and predictors of comorbidity and deaths. PLoS One. 2019;14(8):e0221518.CrossRefPubMedPubMedCentral Silva-Junior AL, Alves FS, Kerr MWA, Xabregas LA, Gama FM, Rodrigues MGA, et al. Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: epidemiology and predictors of comorbidity and deaths. PLoS One. 2019;14(8):e0221518.CrossRefPubMedPubMedCentral
13.
go back to reference Vasquez L, Oscanoa M, Tello M, Tapia E, Maza I, Geronimo J. Factors associated with the latency to diagnosis of childhood cancer in Peru. Pediatric Blood Cancer. 2016;63(11):1959–65.CrossRefPubMed Vasquez L, Oscanoa M, Tello M, Tapia E, Maza I, Geronimo J. Factors associated with the latency to diagnosis of childhood cancer in Peru. Pediatric Blood Cancer. 2016;63(11):1959–65.CrossRefPubMed
14.
go back to reference Vasquez L, Diaz R, Chavez S, Tarrillo F, Maza I, Hernandez E, et al. Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru. Pediatric Blood Cancer. 2018;65(6):e27007.CrossRefPubMed Vasquez L, Diaz R, Chavez S, Tarrillo F, Maza I, Hernandez E, et al. Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru. Pediatric Blood Cancer. 2018;65(6):e27007.CrossRefPubMed
15.
go back to reference Team WER. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;2014(371):1481–95.CrossRef Team WER. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;2014(371):1481–95.CrossRef
16.
go back to reference World Health Organization. International classification of disease and related health problems: 10th revision. Geneva: World Health Organization; 1992. World Health Organization. International classification of disease and related health problems: 10th revision. Geneva: World Health Organization; 1992.
18.
go back to reference Carioli G, La Vecchia C, Bertuccio P, Rodriguez T, Levi F, Boffetta P, et al. Cancer mortality predictions for 2017 in Latin America. Ann Oncol. 2017;28(9):2286–97.CrossRefPubMed Carioli G, La Vecchia C, Bertuccio P, Rodriguez T, Levi F, Boffetta P, et al. Cancer mortality predictions for 2017 in Latin America. Ann Oncol. 2017;28(9):2286–97.CrossRefPubMed
19.
go back to reference Carioli G, Bertuccio P, Malvezzi M, Rodriguez T, Levi F, Boffetta P, et al. Cancer mortality predictions for 2019 in Latin America. Int J Cancer. 2020;147(3):619–32.CrossRefPubMed Carioli G, Bertuccio P, Malvezzi M, Rodriguez T, Levi F, Boffetta P, et al. Cancer mortality predictions for 2019 in Latin America. Int J Cancer. 2020;147(3):619–32.CrossRefPubMed
22.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–51.CrossRefPubMed
23.
go back to reference Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004;60(4):1005–14.CrossRefPubMed Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ. Comparability of segmented line regression models. Biometrics. 2004;60(4):1005–14.CrossRefPubMed
24.
go back to reference Barbosa IR, de Souza DL, Bernal MM, do CC Costa Í. Cancer mortality in Brazil: temporal trends and predictions for the year 2030. Medicine. 2015;94(16):e746. Barbosa IR, de Souza DL, Bernal MM, do CC Costa Í. Cancer mortality in Brazil: temporal trends and predictions for the year 2030. Medicine. 2015;94(16):e746.
25.
go back to reference Moller B, Fekjær H, Hakulinen T, Tryggvadóttir L, Storm HH, Talback M, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer. 2002;11:S1–96. Moller B, Fekjær H, Hakulinen T, Tryggvadóttir L, Storm HH, Talback M, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer. 2002;11:S1–96.
26.
go back to reference Møller B, Fekjær H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22(17):2751–66.CrossRefPubMed Møller B, Fekjær H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22(17):2751–66.CrossRefPubMed
27.
go back to reference Jakab Z, Juhasz A, Nagy C, Schuler D, Garami M. Hungarian Paediatric Haemato-Oncology N. Trends and territorial inequalities of incidence and survival of childhood leukaemia and their relations to socioeconomic status in Hungary, 1971–2015. Eur J Cancer Prev. 2017;26:S183–S90 Joining forces for better cancer registration in Europe.CrossRefPubMed Jakab Z, Juhasz A, Nagy C, Schuler D, Garami M. Hungarian Paediatric Haemato-Oncology N. Trends and territorial inequalities of incidence and survival of childhood leukaemia and their relations to socioeconomic status in Hungary, 1971–2015. Eur J Cancer Prev. 2017;26:S183–S90 Joining forces for better cancer registration in Europe.CrossRefPubMed
28.
go back to reference Marcos-Gragera R, Galceran J, Martos C, de Munain A, Vicente-Raneda M, Navarro C, et al. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007. Clin Transl Oncol. 2017;19(3):301–16.CrossRefPubMed Marcos-Gragera R, Galceran J, Martos C, de Munain A, Vicente-Raneda M, Navarro C, et al. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007. Clin Transl Oncol. 2017;19(3):301–16.CrossRefPubMed
29.
go back to reference Force LM, Abdollahpour I, Advani SM, Agius D, Ahmadian E, Alahdab F, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017. Lancet Oncol. 2019;20(9):1211–25.CrossRef Force LM, Abdollahpour I, Advani SM, Agius D, Ahmadian E, Alahdab F, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017. Lancet Oncol. 2019;20(9):1211–25.CrossRef
30.
go back to reference Page KR, Doocy S, Ganteaume FR, Castro JS, Spiegel P, Beyrer C. Venezuela's public health crisis: a regional emergency. Lancet. 2019;393(10177):1254–60.CrossRefPubMed Page KR, Doocy S, Ganteaume FR, Castro JS, Spiegel P, Beyrer C. Venezuela's public health crisis: a regional emergency. Lancet. 2019;393(10177):1254–60.CrossRefPubMed
31.
go back to reference Poole C, Greenland S, Luetters C, Kelsey JL, Mezei G. Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol. 2006;35(2):370–84.CrossRefPubMed Poole C, Greenland S, Luetters C, Kelsey JL, Mezei G. Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol. 2006;35(2):370–84.CrossRefPubMed
32.
go back to reference Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li C-K, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104–e16.CrossRefPubMed Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li C-K, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104–e16.CrossRefPubMed
33.
go back to reference Escamilla-Santiago RA, Narro-Robles J, Fajardo-Gutiérrez A, Rascón-Pacheco RA, López-Cervantes M. Tendencia de la mortalidad por cáncer en niños y adolescentes según grado de marginación en México (1990-2009). Salud Publ Mex. 2012;54(6):587–94.CrossRef Escamilla-Santiago RA, Narro-Robles J, Fajardo-Gutiérrez A, Rascón-Pacheco RA, López-Cervantes M. Tendencia de la mortalidad por cáncer en niños y adolescentes según grado de marginación en México (1990-2009). Salud Publ Mex. 2012;54(6):587–94.CrossRef
34.
go back to reference Hashemizadeh H, Boroumand H, Noori R, Darabian M. Socioeconomic status and other characteristics in childhood leukemia. Iran J Ped Hematol Oncol. 2013;3(1):182.PubMedPubMedCentral Hashemizadeh H, Boroumand H, Noori R, Darabian M. Socioeconomic status and other characteristics in childhood leukemia. Iran J Ped Hematol Oncol. 2013;3(1):182.PubMedPubMedCentral
35.
go back to reference Dávila-Cervantes CA, Agudelo-Botero M. Health inequalities in Latin America: persistent gaps in life expectancy. Lancet Planetary Health. 2019;3(12):e492–e3.CrossRefPubMed Dávila-Cervantes CA, Agudelo-Botero M. Health inequalities in Latin America: persistent gaps in life expectancy. Lancet Planetary Health. 2019;3(12):e492–e3.CrossRefPubMed
36.
go back to reference Adam M, Kuehni CE, Spoerri A, Schmidlin K, Gumy-Pause F, Brazzola P, et al. Socioeconomic status and childhood leukemia incidence in Switzerland. Front Oncol. 2015;5:139.CrossRefPubMedPubMedCentral Adam M, Kuehni CE, Spoerri A, Schmidlin K, Gumy-Pause F, Brazzola P, et al. Socioeconomic status and childhood leukemia incidence in Switzerland. Front Oncol. 2015;5:139.CrossRefPubMedPubMedCentral
37.
go back to reference Seah T, Zhang C, Halbert J, Prabha S, Gupta S. The magnitude and predictors of therapy abandonment in pediatric central nervous system tumors in low-and middle-income countries: systematic review and meta-analysis. Pediatr Blood Cancer. 2019;66(6):e27692.CrossRefPubMed Seah T, Zhang C, Halbert J, Prabha S, Gupta S. The magnitude and predictors of therapy abandonment in pediatric central nervous system tumors in low-and middle-income countries: systematic review and meta-analysis. Pediatr Blood Cancer. 2019;66(6):e27692.CrossRefPubMed
38.
go back to reference Navarrete M, Rossi E, Brivio E, Carrillo J, Bonilla M, Vasquez R, et al. Treatment of childhood acute lymphoblastic leukemia in Central America: a lower-middle income countries experience. Pediatr Blood Cancer. 2014;61(5):803–9.CrossRefPubMed Navarrete M, Rossi E, Brivio E, Carrillo J, Bonilla M, Vasquez R, et al. Treatment of childhood acute lymphoblastic leukemia in Central America: a lower-middle income countries experience. Pediatr Blood Cancer. 2014;61(5):803–9.CrossRefPubMed
40.
go back to reference Marinho F, de Azeredo Passos VM, Malta DC, França EB, Abreu DM, Araújo VE, et al. Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the global burden of disease study 2016. Lancet. 2018;392(10149):760–75.CrossRef Marinho F, de Azeredo Passos VM, Malta DC, França EB, Abreu DM, Araújo VE, et al. Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the global burden of disease study 2016. Lancet. 2018;392(10149):760–75.CrossRef
41.
go back to reference MdFMd S, Malta DC, França EB, Barreto ML. Changes in health and disease in Brazil and its states in the 30 years since the unified healthcare system (SUS) was created. Cienc Saude Colet. 2018;23:1737–50.CrossRef MdFMd S, Malta DC, França EB, Barreto ML. Changes in health and disease in Brazil and its states in the 30 years since the unified healthcare system (SUS) was created. Cienc Saude Colet. 2018;23:1737–50.CrossRef
Metadata
Title
Leukemia mortality in children from Latin America: trends and predictions to 2030
Authors
J. Smith Torres-Roman
Bryan Valcarcel
Pedro Guerra-Canchari
Camila Alves Dos Santos
Isabelle Ribeiro Barbosa
Carlo La Vecchia
Katherine A. McGlynn
Dyego Leandro Bezerra de Souza
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Leukemia
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02408-y

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue